Shortage of Contrast for Imaging Services

Because of a global shortage of iodinated contrast material (Omnipaque) caused by temporary overseas manufacturing disruptions, ChristianaCare is taking steps to preserve supply so that it remains available for the most time-sensitive and urgent patient needs. (Learn more in our frequently asked questions.)

Omnipaque contrast is the most widely used contrast material for CT scans and radiographic examinations at ChristianaCare facilities. It is also used for cardiac imaging and interventions, and in the GI lab, Surgicenter and other settings.

The shortage is expected to last several weeks, and likely into the summer months.

Hospitals and health care organizations worldwide are managing the effects of the shortage and the impact to patient care.

ChristianaCare is making every effort to meet the needs of patients who need this product in their procedures. We are working individually with physicians to prioritize those patients with the most urgent needs.

Wherever possible, we are using alternative contrast material and limiting its use to ensure adequate supplies for time sensitive and emergent exams. It is possible that some elective procedures that use this product will need to be delayed.

ChristianaCare will continue to look for options to minimize disruptions created by the shortage, as we serve our community as expert, caring partners in health.

Learn more in our frequently asked questions (FAQs).

COVID-19: Click here for what to expect at ChristianaCare during COVID-19

ChristianaCare

Shortage of Contrast for Imaging Services

Because of a global shortage of iodinated contrast material (Omnipaque) caused by temporary overseas manufacturing disruptions, ChristianaCare is taking steps to preserve supply so that it remains available for the most time-sensitive and urgent patient needs. (Learn more in our frequently asked questions.)

Omnipaque contrast is the most widely used contrast material for CT scans and radiographic examinations at ChristianaCare facilities. It is also used for cardiac imaging and interventions, and in the GI lab, Surgicenter and other settings.

The shortage is expected to last several weeks, and likely into the summer months.

Hospitals and health care organizations worldwide are managing the effects of the shortage and the impact to patient care.

ChristianaCare is making every effort to meet the needs of patients who need this product in their procedures. We are working individually with physicians to prioritize those patients with the most urgent needs.

Wherever possible, we are using alternative contrast material and limiting its use to ensure adequate supplies for time sensitive and emergent exams. It is possible that some elective procedures that use this product will need to be delayed.

ChristianaCare will continue to look for options to minimize disruptions created by the shortage, as we serve our community as expert, caring partners in health.

Learn more in our frequently asked questions (FAQs).

COVID-19: Click here for what to expect at ChristianaCare during COVID-19

Kidney Transplant Program

Kidney Transplant Evaluation

Our kidney transplant team relies on the following consultations and tests to assess your overall health.

The initial evaluation consultations consist of:

  • Transplant education.
  • Medical evaluation by a nephrologist.
  • Psychosocial evaluation.
  • Financial evaluation.
  • Initial tests: Lab work (blood tests), X-ray and EKG.

The comprehensive testing consists of additional:

  • Cardiac studies.
  • Imaging studies.
  • As needed for some patients: standard health screenings, including colonoscopy, prostate screening, mammogram, Pap test and/or dental exam.

At your kidney transplant evaluation appointment you will also meet with several other team members, including:

  • A social worker, who reviews your support system and insurance coverage.
  • A dietitian, who reviews your dietary habits and, if needed, helps you change them.
  • A financial analyst, who determines if you have any medically related financial challenges that need to be addressed.
  • A pharmacist, who reviews your allergy information and current medications, and discusses medications you will take after your kidney transplant.

Finally, you will meet with a kidney transplant coordinator, who becomes your point of contact with our program. The coordinator reviews your test results and helps to arrange further tests if needed. Once all the tests are complete, our team works as a committee to determine if you are a good candidate to go on the list to receive a kidney transplant.

Once the evaluation is complete, the patient’s chart will be reviewed by the physicians and multi-disciplinary team at the weekly selection committee meeting. The selection committee may approve the patient for listing, require additional information prior to making a decision, or determine that the patient is not a candidate for transplantation. The patient, referring physician, and dialysis unit (if applicable) will receive letters notifying of the committee’s decision.

Once a patient has been approved for transplant listing, insurance authorization will be obtained if needed prior to being placed on the national transplant waiting list.